Structure-activity studies with somatostatin: role of lysine in positions 4 and 9 for gastric activity
暂无分享,去创建一个
[1] D. Veber,et al. Somatostatin analogs which define the role of the lysine-9 amino group. , 2009, International journal of peptide and protein research.
[2] B. Hirst,et al. Cyclic hexa- and pentapeptide somatostatin analogues with reduced gastric inhibitory activity , 1984, Peptides.
[3] O. Rorstad,et al. Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells. , 1983, Endocrinology.
[4] D. Coy,et al. Position 4 substituted somatostatin analogs: increased binding to somatostatin receptors in pituitary and brain. , 1983, Life sciences.
[5] B. Hirst,et al. Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats , 1982, Regulatory Peptides.
[6] D. Coy,et al. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs. , 1981, Endocrinology.
[7] B. Shaw,et al. Structure-activity studies with somatostatin: The role of tryptophan in position 8 , 1980, Regulatory Peptides.
[8] J. Morley,et al. Non-reducible cyclic, and azaphenylalanyl6 analogues of somatostatin. , 1980, European journal of pharmacology.
[9] B. Hirst,et al. Structure‐activity relationships of eighteen somatostatin analogues on gastric secretion. , 1978, The Journal of physiology.
[10] A. Schally,et al. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[11] W. Vale,et al. Hypothalamic Hypophysiotropic Hormones , 1975 .